| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | REYNOLDS AMERICAN INC | 7,221,145 | 539,131,000 | 41.35% | ||
| 2 | ALKERMES PLC SHS | 4,778,633 | 307,457,000 | 23.58% | ||
| 3 | PROTHENA CORP PLC | 5,527,525 | 291,135,000 | 22.33% | ||
| 4 | NORTHWEST BIOTHERAPEUTICS INC | 16,721,392 | 166,043,000 | 12.74% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001213900-15-006768, filed 2015.09.04).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
